Valuation : Tasly Pharmaceutical Group Co., Ltd

Market Cap 21.93B 3.26B 2.81B 2.64B 2.41B 4.52B 310B 4.55B 31.25B 12.16B 157B 12.25B 11.98B 521B P/E 2026 *
16x
P/E 2027 * 13.3x
Enterprise Value 20.39B 3.03B 2.61B 2.45B 2.24B 4.2B 288B 4.23B 29.05B 11.3B 146B 11.38B 11.14B 484B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 1.74x
Free-Float
47.11%
Yield 2026 *
2.81%
Yield 2027 * 3.52%
1 day-1.41%
1 week-1.94%
Current month-8.93%
1 month-7.56%
3 months+4.34%
6 months+2.73%
Current year-2.59%
1 week 14.59
Extreme 14.59
15.04
1 month 14.59
Extreme 14.59
16.22
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.72
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 08/05/2024
Director of Finance/CFO 49 09/07/2018
Chief Investment Officer 45 01/05/2025
Director TitleAgeSince
Director/Board Member 72 02/06/2021
Chairman 54 10/08/2026
Director/Board Member 58 08/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%-1.94%-11.14%+5.99% 3.31B
+0.78%+2.15%-12.49%-6.96% 13.26B
-2.41%+0.50%-33.04%-56.86% 4.99B
-3.11%-1.57%-8.27%-7.32% 4.66B
-1.55%-3.16%-2.75%-31.25% 4.02B
-1.07%+1.95%-21.84%+3.65% 3.59B
+3.31%+6.11%+0.23%-0.92% 3.43B
-1.65%-3.87%-23.53%-14.45% 2.38B
-1.52%+1.41%-27.89%-15.73% 1.72B
-1.33%+2.78%-1.99%-14.29% 1.7B
Average -1.00%-0.02%-14.27%-13.81% 4.31B
Weighted average by Cap. -0.66%-0.06%-13.98%-13.74%

Financials

2026 *2027 *
Net sales 8.56B 1.27B 1.1B 1.03B 940M 1.77B 121B 1.78B 12.2B 4.75B 61.44B 4.78B 4.68B 203B 9.32B 1.39B 1.19B 1.12B 1.02B 1.92B 132B 1.94B 13.28B 5.17B 66.88B 5.2B 5.09B 221B
Net income 1.37B 204M 176M 165M 151M 283M 19.44B 285M 1.96B 761M 9.86B 767M 750M 32.63B 1.65B 246M 212M 199M 181M 341M 23.38B 343M 2.35B 916M 11.86B 923M 903M 39.26B
Net Debt -1.54B -230M -198M -186M -169M -318M -21.85B -321M -2.2B -856M -11.08B -862M -843M -36.68B -5.71B -850M -731M -687M -627M -1.18B -80.83B -1.19B -8.14B -3.17B -40.99B -3.19B -3.12B -136B
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
31/08/26 CN¥14.68 -1.41% 16,219,530
28/08/26 CN¥14.89 +0.47% 15,263,887
27/08/26 CN¥14.82 +0.34% 13,596,225
26/08/26 CN¥14.77 +0.14% 13,777,567
25/08/26 CN¥14.75 -0.47% 12,437,989
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.89CNY
Average target price
16.93CNY
Spread / Average Target
+13.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock